FDA Approves First Treatment for Post- Transplant Infection that is Resistant to Other Drugs
The U.S. Food and Drug Administration approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients (12...
FDA Approves First Treatment for Post- Transplant Infection that is Resistant to Other Drugs
FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism
FDA Expands Eligibility for COVID-19 Vaccine Boosters
FDA Provides New Draft Guidance on Premarket Submissions for Device Software Functions
FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years